Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
135
datasets available to search
ShareScore release 0.9.0
Dataset results
135 results for “cutaneous T-cell lymphoma”
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov study NCT00611208. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)
ClinicalTrials.gov study NCT00091559. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov study NCT01007448. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov study NCT00490776. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00958074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib/Dexamethasone Therapy in Patients With Relapsed and/or Refractory Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT03487133. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00877656. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT02301494. IPD Sharing: NO. Countries: 0. Publications: 1.
CPG 7909 in Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00043420. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov study NCT01433731. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01800838. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT05380635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT02676778. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin
ClinicalTrials.gov study NCT05886478. IPD Sharing: YES. Countries: 4. Publications: 0.
Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas
ClinicalTrials.gov study NCT02158975. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov study NCT00211198. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00438802. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of Selinexor in Relapsed or Refractory Peripheral T-cell Lymphoma or Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT02314247. IPD Sharing: YES. Countries: 2. Publications: 0.
RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00667017. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00182637. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.